Monitoring free extracellular valproic acid by microdialysis in epileptic patients

Therapeutic Drug Monitoring

Volumn 18, Issue 1, 1996, Pages 14-18

  Ståhle, Lars ^a,b   Alm, Christina ^a   Ekquist, Brita ^a   Lundquist, Birgitta ^a   Tomson, Torbjörn ^c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c STOCKHOLM SÖDER HOSPITAL   (Sweden)

Author keywords

Epilepsy; Microdialysis; Pharmacokinetics; Protein binding; Therapeutic drug monitoring; Valproic acid

Indexed keywords

VALPROIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIALYSATE; DRUG BLOOD LEVEL; DRUG MONITORING; EPILEPSY; FEMALE; GAS CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MALE; MICRODIALYSIS; PRIORITY JOURNAL;

ADULT; ANTICONVULSANTS; CHROMATOGRAPHY, GAS; EPILEPSY; EXTRACELLULAR SPACE; FEMALE; HUMANS; MALE; MICRODIALYSIS; MIDDLE AGED; PROTEIN BINDING; VALPROIC ACID;

EID: 0030043508     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-199602000-00003     Document Type: Article

References (12)

1. Ungerstedt U. Measurement of neurotransmitter release by intracranial dialysis. In: Marsden CA, ed. Measurement of neurotransmitter release in vivo. London: Wiley, 1984:81-105.
2. Ungerstedt U. Introduction to microdialysis. In: Robinson T, Justice J, eds. Methods in neuroscience, Amsterdam: Elsevier, 1991:3-22.
3. Ståhle L. Use of microdialysis in pharmacokinetics and pharmacodynamics. In: Robinson T, Justice J, eds. Methods in neuroscience. Amsterdam: Elsevier, 1991:155-174.
4. Ståhle L, Arner P, Ungerstedt U. Drug distribution studied by microdialysis. III. Levels of caffeine in human subcutaneous adipose tissue. Life Sci 1991;49:1853-8.
5. Chadwick DW. Concentration-effect relationships of valproic acid. Clin Pharmacokinet 1985;10:155-63.
6. Gram L, Drachmann Bentsen K. Valproate: an updated review. Acta Neurol Scand 1985;72:129-39.
7. Herngren L, Lundberg B, Nehrgårdh A. Pharmacokinetics of total and free valproic acid during monotherapy in infants. J Neurol 1991;238:315-9.
8. Kodama Y, Kuranari M, Tsutsumi K, Kimoto H, Fujii I, Takeyama M. Prediction of unbound serum valproic acid concentration by using in vivo binding parameters. Ther Drug Monit 1992;14:349-53.
9. Barre J, Chamouard JM, Houin G, Tillement JP. Comparison of equilibrium dialysis, ultrafiltration and ultracentrifugation to determine the plasma protein binding characteristics of a drug: application to valproic acid. Clin Pharmacokinet 1984;9(suppl 1):86-7.
10. Ståhle L. Estimation of pharmacokinetic parameters from microdialysis data. Eur J Clin Pharmacol 1992;43:289-94.
11. Box GEP, Hunter JS. Statistics for Experimenters. Wiley, New York, 1978
12. Riva R, Albani F, Contin M, et al. Mechanism of altered drug binding to serum proteins in pregnant women: studies with valproic acid. Ther Drug Monit 1984;6:25-30.